Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature within the Process of Vascular Remodeling: Cellular Basis, Clinical Relevance, and Implications for Stem Cell TherapyMissing Concepts in De Novo Pulp RegenerationHyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosisIsolation and characterization of a novel strain of mesenchymal stem cells from mouse umbilical cord: potential application in cell-based therapy.Autologous Adipose Stem Cell Therapy for Autonomic Nervous System Dysfunction in Two Young Patients.Chronic allergen challenge induces pulmonary extramedullary hematopoiesis.Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation.Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn.Isolation and characterization of novel murine epiphysis derived mesenchymal stem cells.Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.Potential role of mesenchymal stem cells in alleviating intestinal ischemia/reperfusion impairmentComparative evaluation of differentiation potential of menstrual blood- versus bone marrow-derived stem cells into hepatocyte-like cells.Systemic infusion of mesenchymal stem cells improves cell-based bone regeneration via upregulation of regulatory T cells.Mesenchymal stem cells ameliorate Th1-induced pre-eclampsia-like symptoms in mice via the suppression of TNF-α expression.The multiple functional roles of mesenchymal stem cells in participating in treating liver diseasesCanine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α.Mitochondrial function and energy metabolism in umbilical cord blood- and bone marrow-derived mesenchymal stem cells.In quest of optimal drug-supported and targeted bone regeneration in the cranio facial area: a review of techniques and methods.Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells.Osteogenic differentiation of stem cells derived from menstrual blood versus bone marrow in the presence of human platelet releasate.Fas ligand regulates the immunomodulatory properties of dental pulp stem cellsThe role of recipient T cells in mesenchymal stem cell-based tissue regenerationInterplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration.Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic micePotency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissuesMesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide.Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro.The Effects of Endocrine Disruptors on Adipogenesis and Osteogenesis in Mesenchymal Stem Cells: A Review.Effects of long-term hypoxia and pro-survival cocktail in bone marrow-derived stromal cell survivalChondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation.Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential.Bone marrow and pancreatic islets: an old story with new perspectives.Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation.Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies.Current applications of human pluripotent stem cells: possibilities and challenges.
P2860
Q26746104-99595EF6-EBBB-4A0D-9F84-F66578D4AFD8Q26748652-921E6E34-602D-4445-B247-E2B7364D8EE4Q26765919-4BF68000-F9DD-45D6-A749-9546CDF9E7ADQ26864398-911C3E2B-32DB-4D49-8FCC-110B91CA7653Q30498118-BC9E9902-A423-47DE-8406-6B60FC41C398Q31134041-C97DEE41-762A-4686-BD34-229DAD0CCAE0Q33168014-B48239D6-3F4F-437E-9FB1-8C6937F43D3CQ33862165-6912F249-28B1-4E02-BBD4-678D02AB3F53Q33939130-113BB404-5B1E-4F0A-9572-383280133779Q34170290-7CFD5A61-E6E7-4C83-BFCA-327CC7027D6EQ34257138-804296FB-EEC4-4BFC-8B0C-DB7AA17929B1Q34663693-54675B77-D2A6-4DB3-A644-954DF0D86EB0Q34994703-0B7AA3E5-7AD1-4641-8404-58729959AFE4Q35088050-4476532B-1F58-428E-9948-185CAF10341CQ35097782-4B537CDE-694C-4516-8EED-CCC91BA05ADBQ35099504-019B946D-1FB2-4762-9378-66B6BE7C3D57Q35206489-0CB3836A-A748-4D8E-A4F0-6DE8CA3C06CCQ35599947-BCC6AD47-91F3-4133-AC37-C52E408AB6FAQ35600853-6966D90F-1F94-4F89-9616-F5B8A7866008Q35760116-818D8A24-85FD-4FAE-805E-7FAF7DCBE044Q35874102-63D9C119-5E93-4193-9672-3C162B3F1D52Q36065208-71789C35-55E5-484A-81C6-3313FF8153F4Q36166509-40FDC95A-5367-4ECD-8B03-B2A6BAAE7034Q36247051-6E4DAE86-B560-4A4C-94C6-4182AA2D5021Q36268038-6B594C78-F45E-4D25-9CF1-563C2169CF6EQ36375063-89D299CE-322C-4D70-A7BC-265644FB86F0Q36776849-16546F35-A2C2-4BD8-94C4-2FF516E60211Q36925952-A81C2987-1A23-4FD0-A539-C0125482AAD5Q37203386-78EE5A91-E749-40B6-AB4A-0AACA5EF8F8FQ37273157-E6B00F53-28A7-4B9B-A35B-3D8AD1171A05Q37372319-6D4F8567-32FE-4FFA-BDA9-34A6F2ECAB6DQ37570411-B38D0F08-43AD-4273-8C57-A66612A50A27Q37592400-E4F7776D-8FF6-4D4B-B7E9-DA621ED4ADD7Q37620828-6BEBA6F0-741C-42C0-844E-AA6FB13B5744Q37628982-EC98268E-4DF4-4C9A-8297-9663323E4BA9Q37780807-C15205D3-8602-4E43-A28A-8EE0FEF36C88Q37830375-CBF36167-0A97-469B-8B4A-A8E5E0D27D68Q37859370-AB179A74-A666-4B2D-9F48-F884E3FEDAE0Q37947420-218F910E-FB77-4271-8BE6-A323E6698AB4Q37997154-0B725576-F3CE-4056-863C-173B14F0886E
P2860
Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunomodulatory properties of ...... for immune-mediated disorders.
@en
Immunomodulatory properties of ...... for immune-mediated disorders.
@nl
type
label
Immunomodulatory properties of ...... for immune-mediated disorders.
@en
Immunomodulatory properties of ...... for immune-mediated disorders.
@nl
prefLabel
Immunomodulatory properties of ...... for immune-mediated disorders.
@en
Immunomodulatory properties of ...... for immune-mediated disorders.
@nl
P2093
P356
P1476
Immunomodulatory properties of ...... for immune-mediated disorders.
@en
P2093
Marc Schmitz
Ralf Wassmuth
Rebekka Wehner
Senming Zhao
P304
P356
10.1089/SCD.2009.0345
P577
2010-05-01T00:00:00Z